Retraction Note: Clinical significance of p95HER2 overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies
Crossref DOI link: https://doi.org/10.1038/bjc.2014.314
Published Online: 2014-06-10
Published Print: 2014-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tural, D
Serdengecti, S
Demirelli, F
Öztürk, T
İlvan, S
Turna, H
Özgüroglu, M
Büyükünal, E
License valid from 2014-06-01
Article History
First Online: 10 June 2014